Since FDA approval is still an uncertainty, the question which begs to be answered is, are there enough other market opportunities for this company to still make it a worthwhile investment.
I too would love to see your articles. I followed you but nothing comes up as being written you by currently. It's easy to say you have a perfect track record if you never actually publish your stock suggestions! :-) Would love for you to share some ideas. If you are as good as you'd say, I'd be happy to pay for your advice. But the proof would have to be in the pudding.
Latest Comments
Gartman Nails It Again
Me neither. Mr. Knight can you please elaborate on the significance of this chart?
Cool Video: Vertical Farming
Excellent points
Cardiome Pharma: Why This Bio Gem Could Be An Easy Double This Year
Since FDA approval is still an uncertainty, the question which begs to be answered is, are there enough other market opportunities for this company to still make it a worthwhile investment.
An Interview With Sanjeev Sharma
I too would love to see your articles. I followed you but nothing comes up as being written you by currently. It's easy to say you have a perfect track record if you never actually publish your stock suggestions! :-) Would love for you to share some ideas. If you are as good as you'd say, I'd be happy to pay for your advice. But the proof would have to be in the pudding.
Vishay Intertechnology: Long-Term Trend Projections Supported By Recent Developments
Thanks, there's not enough coverage on this company.
Living In The Land Of Worries, Part 1
Lol, me too!